Related Experiment Video
Updated: Mar 25, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
Olga Villamizar1,2, Christopher B Chambers1, Janice M Riberdy3
1Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Abstract:
In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently resistant to Fas-mediated apoptosis, evade Fas signals through down regulation of Fas and produce soluble Fas proteins that bind FasL thereby blocking apoptosis. Soluble Fas (sFas) is an alternative splice product of Fas pre-mRNA, commonly created by exclusion of transmembrane spanning sequences encoded within exon 6 (FasΔEx6). Long non-coding RNAs (lncRNAs) interact with other RNAs, DNA, and proteins to regulate gene expression. One lncRNA, Fas-antisense or Saf, was shown to participate in alternative splicing of Fas pre-mRNA through unknown mechanisms. We show that Saf is localized in the nucleus where it interacts with Fas receptor pre-mRNA and human splicing factor 45 (SPF45) to facilitate alternative splicing and exclusion of exon 6. The product is a soluble Fas protein that protects cells against FasL-induced apoptosis. Collectively, these studies reveal a novel mechanism to modulate this critical cell death program by an lncRNA and its protein partner.
Insights
A novel long non-coding RNA, Saf, interacts with splicing factor SPF45 to regulate Fas receptor alternative splicing. This mechanism produces soluble Fas (sFas) protein, protecting cancer cells from apoptosis and promoting tumor survival.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Programmed cell death (apoptosis) is crucial for multicellular organisms.
- Fas receptor (Fas)-Fas ligand (FasL) interaction mediates a key apoptotic pathway.
- Cancer cells often resist Fas-mediated apoptosis by downregulating Fas or producing soluble Fas (sFas).
Purpose of the Study:
- To elucidate the mechanism by which the long non-coding RNA (lncRNA) Saf modulates Fas receptor alternative splicing.
- To identify the protein partners involved in Saf-mediated alternative splicing.
- To understand how this mechanism contributes to cancer cell survival.
Main Methods:
- Nuclear localization studies of Saf.
- RNA immunoprecipitation to detect Saf-Fas pre-mRNA interactions.
- Co-immunoprecipitation to identify protein interactions with Saf.
- Analysis of alternative splicing products and apoptosis assays.
Main Results:
- Saf is localized in the nucleus and interacts with Fas pre-mRNA.
- Saf interacts with the human splicing factor 45 (SPF45).
- This interaction facilitates alternative splicing of Fas pre-mRNA, leading to exon 6 exclusion and production of sFas.
- The resulting sFas protein protects cells from FasL-induced apoptosis.
Conclusions:
- A novel mechanism involving the lncRNA Saf and SPF45 regulates Fas receptor alternative splicing.
- This pathway generates sFas, conferring resistance to apoptosis in neoplastic cells.
- This discovery offers new insights into cancer cell survival strategies and potential therapeutic targets.
Related Concept Videos
RNA Splicing
RNA Splicing
The Extrinsic Apoptotic Pathway
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of Nuclear Protein Sorting
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

